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Background: In recent years, a high prevalence of vitamin D deficiency amongst pregnant women and newborns
has been observed throughout several regions of the world, especially in the presence of preeclampsia (PE) or
obesity (OB). The aim of this study was to investigate whether nonobese and obese preeclamptic pregnant women
and their newborns have low 25(OH)D compared with nonobese and obese nonpreeclamptic pregnant women;
and to verify whether the maternal level of this vitamin correlates with the newborns’ level.
Methods: This is a cross-sectional study conducted with 179 pregnant women recruited immediately before delivery,
divided into four groups: PE+/OB−; PE+/OB+; PE−/OB+; and PE−/OB−, with gestational age ≥ 34 weeks. Maternal
peripheral blood and newborns umbilical cord blood were collected and 25(OH)D levels were measured by
chemiluminescence (LIAISON®).
Results: Infants born to preeclamptic mothers had a lower median 25(OH)D level than those born to nonpreeclamptic
mothers (p < 0.01). Obese pregnant women and their newborns had higher frequencies of 25(OH)D deficiency, but the
difference with respect to nonobese pregnant women and their newborns was not significant. The vitamin D status of
preeclamptic obese women was not worse than that of their nonobese counterparts. Newborns and maternal 25(OH)D
levels were significantly correlated (p = 0.01). Obesity weakened this correlation.
Conclusions: Preeclamptic women and their newborns presented higher frequencies of 25(OH)D deficiency, but
25(OH)D levels were not significantly influenced by obesity. Obese pregnant women transferred less 25(OH)D to their
fetuses.
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Vitamin D deficiency during pregnancy is common [1, 2]
and concerning because of its association with many
conditions, such as preeclampsia (PE), obesity, and ges-
tational diabetes, as well as its medium- and long-term
repercussions for newborns [1, 3, 4].
Classically, emphasis rests on the importance of vitamin
D to bone metabolism [5], but increasingly greater bio-
logical and clinical roles have been attributed to its active
form 1,25(OH)2days in the last years [6]. There has been a
paradigm shift such that, today, 1, 25(OH)2days is consid-
ered a hormone that acts on specific receptors found in at
least 36 different types of cells [6].* Correspondence: homero.rabelo@terra.com.br
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unless otherwise stated.The participation of 1, 25(OH)2days in immune system
regulation has been demonstrated [7, 8], so its deficiency
is now considered a risk factor for inflammatory dis-
eases, such as PE [8–11]. Prepregnancy obesity is also
associated with higher susceptibility to PE [12]. Add-
itionally, studies have shown an inverse relationship be-
tween BMI (Body Mass Index) and vitamin D status
[13–15]. Hence, low vitamin D in obese pregnant
women [16] can contribute to the onset of PE, which is
complex and multifactorial [17].
Since fetal vitamin D status depends on maternal
levels of this vitamin [1, 18], all situations that cause
vitamin D deficiency during pregnancy imply in low
vitamin D in the newborn. Bone (craniotabes, low bone
mineral content, and rickets) [19] and nonbone reper-
cussions (greater risk of respiratory infections, asthma,his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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vitamin D deficiency at birth.
Hence, the objective of this study is to investigate
whether nonobese and obese preeclamptic pregnant
women and their newborns have low 25(OH)D compared
with nonobese and obese nonpreeclamptic pregnant
women; and to verify whether the maternal level of this
vitamin correlates with the newborns’ level.
Methods
Study design and subjects
This cross-sectional study was conducted from November
2012 to March 2013 in the maternity ward of the Hospital
Barão de Lucena in the city of Recife, Northeast Brazil.
The study was approved by the Human Research Ethics
Committee of the Health Sciences Center of the Federal
University of Pernambuco and followed the principles of
the Declaration of Helsinki. Pregnant women were re-
cruited immediately before delivery after signing the in-
formed consent form. They were divided into four groups:
nonobese preeclamptic (PE+/OB−), obese preeclamptic
(PE+/OB+); obese nonpreeclamptic (PE−/OB+); and non-
obese nonpreeclamptic women (PE−/OB−).
All subjects had singleton pregnancies with gestational
age of at least 34 weeks. They were aged 16 to 40 years
and attended the first prenatal care visit before gestational
week 16. The exclusion criteria were hypertension before
gestational week 20, history of chronic hypertension, ges-
tational diabetes, diabetes mellitus, liver or kidney disease,
carrying an infection, or taking anticonvulsants.
Twenty-two of the 201 initially recruited mother-
newborn dyads were excluded because of hemolysis or in-
sufficient blood sample (n = 16), or inappropriate storage
or transportation (n = 6), therefore, the study sample com-
prised 179 mother-newborn dyads.
Study variables
Gestational age was determined by the date of the last
menstrual period. PE was defined as the presence of hyper-
tension (systolic blood pressure level of 140 mmHg or
higher or a diastolic blood pressure level of ≥ 90 mmHg)
after the twentieth week of gestation in previously normo-
tensive women, plus the presence of proteinuria (≥1+ on
dipstick in single urine sample), according to criteria
adopted by the American College of Obstetricians and
Gynecologists (ACOG) [21]. Maternal nutritional status
was assessed by means of BMI obtained in the first pre-
natal consultation before the 16th gestational week.
Women were defined as obese or not according to the
classification developed by Atallah et al. [22] and
adopted by the Ministry of Health of Brazil, which clas-
sifies pregnant women according to the appropriateness
of BMI in relation to gestational age. No measurements
were undertaken to assess women adiposity.Vitamin D status was classified according to the cutoff
points proposed by Holick et al. [23] for adults (pregnant
women), and the same values were used for the newborns
[24]: ≥ 30 ng/mL is considered enough to promote bone
and no bone health, 20 to 29.9 ng/mL indicates insuffi-
ciency and <20 ng/mL deficiency.
A single researcher used a form to interview the partici-
pants after delivery and collect information on socioeco-
nomic and demographic factors, clinical pregnancy data,
amount of exposure to sunlight, frequency of sunscreen
use, newborns weight and length. Newborns nutritional
status was classified according to the appropriateness of
weight in relation to gestational age, using the fetal growth
curve of Lubchenco et al. [25].
Laboratory analyses
Peripheral and umbilical cord blood samples were col-
lected from the mothers and newborns, respectively, using
a Vacuette® tube, which contains clot activator and serum
separator gel. The tubes were immediately centrifuged and
refrigerated to 2-8 °C until the vitamin D level was deter-
mined, no later than 72 h after blood collection. Vitamin
D level was determined by chemiluminescence using the
commercial assay LIAISON 25 OH Vitamin D Total
(310600)®, from DiaSorin Inc. (USA), which has an analyt-
ical measurement range of 4.0 to 150.0 ng/mL. All sam-
ples were analyzed by a single technician using the same
equipment throughout the study period in a reference la-
boratory. The inter-assay coefficient of variation varied
from 6.5 % to 8.1 % during this period, in accordance with
the manufacturer’s standards.
Statistical power and analyses
A retrospective statistical power calculation from the fre-
quencies of vitamin D deficiency observed in PE+/OB− and
PE+/OB+ groups in relation to the PE−/OB− with a signifi-
cance level of 5 % showed a sample power around 95 %.
Normality of continuous variables was checked using a
histogram. Those with symmetric distribution were
expressed as means and standard deviation and the asym-
metric ones as medians and inter quartile range (IQR).
The associations between categorical variables were tested
by the chi-square test. For continuous variables one way
analysis of variance (ANOVA) and the Kruskal-Wallis test
were employed as appropriate. Pearson correlation coeffi-
cient tested the association of two continuous variables.
The Statistical Package for the Social Science (SPSS),
version 13 was used for the statistical analysis. The sig-
nificance level was set at 5% for all tests.
Results
Table 1 shows the socioeconomic and clinical character-
istics of the pregnant women and their newborns.
Around 63 % (58/92) of the preelamptic women were
Table 1 Maternal and newborn characteristicsa according to maternal nutritional status and occurrence of preeclampsia
Variables PE +/OB − PE +/OB+ PE −/OB+ PE −/OB− P-value
(n = 48) (n = 44) (n = 40) (n = 47)
Maternal age (years) 21.0(19.0-27.0) 26.5(21.5-31.5) 27.0(22.0-33.0) 24.0(19.0-29.0) 0.003*
Maternal BMI (kg/m2) 23.7(21.2-25.7) 32.9(31.5-36.8) 32.8(31.6-35.9) 24.2(21.3-26.3) <0.001*
Number of pregnancies
1 70.8% (34) 54.5% (24) 27.5% (11) 34.0% (16) <0.001**
≥2 29.2% (14) 45.5% (20) 72.5% (29) 66.0% (31)
Gestational age (weeks)
<37 25.0% (12) 18.2% (08) 12.5% (05) 14.9% (07) 0.43**
≥37 75.0% (36) 81.8% (36) 87.5% (35) 85.1% (40)
Skin color
White 16.7% (08) 25.0% (11) 17.5% (07) 14.9% (07) 0.62**
Other 83.3% (40) 75.0% (33) 82.5% (33) 85.1% (40)
Per capita family income (in Reais) 312(208–500) 339(211–450) 252.00(169–336) 282.70(200–400) 0.09*
Literacy
Illiterate 2.1% (01) 4.5% (02) 10.0% (04) 10.6% (05) 0.28**
Literate 97.9% (47) 95.5% (42) 90.0% (36) 89.4% (42)
Exposure to sunlight (minutes/day) 20.0(10.0-32.5) 20.0(15.0-35.0) 32.5(15.0-50.0) 20.0(10.0-30.0) 0.16*
Sunscreen
Yes 10.4% (05) 09.1% (04) 07.5% (03) 08.5% (04) 0.97**
No 89.6% (43) 90.9%(40) 92.5% (37) 91.5% (43)
Infant sex
Female 45.8% (22) 59.1% (26) 55.0% (22) 53.2% (25) 0.63**
Male 54.2% (26) 40.9% (18) 45.0% (18) 46.8% (22)
Birth weight (g) 2782.3 ± 750.9 3272.6 ± 648.6 3326.7 ± 589.3 3221.2 ± 544.3 <0.001***
Birth length (cm) 46.5(44.5-48.0) 48.0(47.0-49.0) 49.0(47.0-50.0) 48.0(46.0-49.0) 0.006*
Nutritional status at birth
AGA 58.3% (28) 70.5% (31) 75.0% (30) 83.0% (39) <0.001**
SGA 33.3% (16) 0% (0) 05.0% (02) 04.3% (02)
LGA 08.4% (04) 29.5% (13) 20.0% (08) 12.7% (06)
aValues are shown as mean ± SD, median (inter quartile range) or %. NB: newborn; AGA: appropriate for gestational age; SGA: small for gestational age; LGA: large
for gestational age; OB: obesity; PE: preeclampsia
1.0 Real = US$ 2.0
*Kruskal-Wallis test; **Chi-square test; ***Analysis of variance
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preeclamptic women, and nonobese pregnant women
were younger than the obese. There was a greater per-
centage of small-for-gestational-age (SGA) newborns in
the group PE+/OB− and a higher frequency of large-for-
gestational-age (LGA) newborns in the obese groups
(PE+/OB+ and PE−/OB+).
Preeclamptic women and their newborns had a
higher frequency of 25(OH)D deficiency than nonpree-
clamptic women. The differences of vitamin D status
between PE+/OB− and PE−/OB− pregnant women was
significant (p = 0.0006) as well as between their new-
borns (p = 0.006). The same was observed among thegroups of PE+/OB+ and PE−/OB− (p = 0.002) and between
their newborns (p = 0.03). Women and newborns in the
group PE−/OB+ had a higher frequency of 25(OH)D defi-
ciency than those in the group PE−/OB−, but the differ-
ence was not significant (p = 0.10 e 0.16, respectively). The
vitamin D status of the mother-newborn dyads in group
PE+/OB+ was not worse than that of mother-newborn
dyads in group PE+/OB− (p = 0.62 e 0.72, respectively).
(Table 2).
Preeclamptic women and newborns had a lower median
vitamin D level than the nonpreeclamptic women and
newborns (Fig. 1). The median differences of vitamin D
between PE+/OB− and PE−/OB− groups were significant
Table 2 Distribution of the 25(OH)D status among
pregnant women and newborns
25(OH)D PE +/OB− PE +/ OB+ PE −/ OB+ PE −/OB− P-
value*(n = 48) (n = 44) (n = 40) (n = 47)
Pregnant women
Adequate 08.3 %(04) 04.6 %(02) 20.0 %(08) 17.0 %(08) 0.002
Insufficient 39.6 %(19) 47.7 %(21) 47.5 %(19) 68.1 %(32)
Deficient 52.1 %(25) 47.7 %(21) 32.5 %(13) 14.9 %(07)
Newborns
Adequate 33.3 %(16) 36.4 %(16) 52.5 %(21) 57.4 %(27) 0.06
Insufficient 52.1 %(25) 54.5 %(24) 40.0 %(16) 42.6 %(20)
Deficient 14.6 %(07) 09.1 %(04) 07.5 %(03) 0 % (0)
PE: preeclampsia; OB: obesity; *Chi-square test
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neonates (p = 0.007). The same was observed between
the PE+/OB+ and PE−/OB− groups (p = 0.0003 for preg-
nant women and p = 0.002 for newborns). However, when
analyzing the median differences between PE−/OB+
and PE−/OB− groups we found no statistical signifi-
cance (p = 0.22 among pregnant women and p = 0.10
among neonates). The median 25(OH)D level of all
newborns was roughly one-third higher than that of all
mothers (Fig. 1).
Fig. 2 shows that the 25(OH)D levels of nonobese
women and their newborns were strongly and positively
correlated; the 25(OH)D levels in obese women and
their newborns were also positively correlated, but not
as much. The correlations in all groups were significant
(p = 0.01).
Discussion
Preeclampsia was associated with a lower median vita-
min D and a higher frequency of vitamin D deficiency in
pregnant women and their newborns. Other studies haveFig. 1 Median, inter quartile range and minimum and maximum values of
blood (B). PE: preeclampsia; OB: obesity. *Kruskal-Wallis testalso reported worse vitamin D status in preeclamptic
women and their newborns [9–11, 26]. Robinson et al.
[11] and Baker et al. [10] found 25(OH)D deficiency per-
centages of 54% and 26%, respectively, in severely pre-
eclamptic American women, and both percentages
significantly exceeded those in nonpreeclamptic women.
These studies used the same vitamin D status cutoff
points as the present study. In another case–control
study, Bodnar et al. [9] found a higher percentage of
vitamin D deficiency in American women who devel-
oped PE than in controls (p = 0.08). Likewise, infants
born to preeclamptic mothers had significant worse
25(OH)D status than those born to control mothers.
Studies have postulated that maternal vitamin D status
affects the risk of preeclampsia [27]. This condition can be
partly explained by the manner in which the trophoblast is
implanted in the endometrium: an exacerbated maternal
immune response (increase of proinflammatory cytokines)
allows only superficial implantation, leading to lower ma-
ternal tolerance of the fetus [17, 28]. The immunomodu-
lating properties of the active form of vitamin D may be
essential during trophoblast implantation, so vitamin D
deficiency at the beginning of pregnancy could cause an
unbalance between pro- and anti-inflammatory cytokines,
constituting a risk factor for PE [29].
Baker et al. [10] and Bodnar et al. [9] collected blood
from pregnant women in the first half of pregnancy and
found that low 25(OH)D levels precede clinical PE pres-
entation. Thus, higher causal inference may be specu-
lated, and perhaps low vitamin D levels at the beginning
of pregnancy may have had some effect on the complex
PE pathophysiology.
The study results show greater vitamin D deficiency in
obese women, but the difference was not significant.
Bodnar et al. [16] also found a higher percentage of
mother-NB dyads with 25(OH)D levels below 20 ng/mL
when prepregnancy BMI ≥ 30 kg/m2 (p < 0.05). Low25(OH)D in pregnant women (A) and newborns – umbilical cord
Fig. 2 Correlations between maternal and newborn (umbilical cord blood) levels of 25(OH)D. *p = 0.01
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vitamin’s fat-soluble nature: as the percentage of body
fat increases, serum 25(OH)D level decreases [13].
Surprisingly, the group PE+/OB+ did not have worse
25(OH)D status than the group PE+/OB−. Studies testing
serum levels of 25(OH)D in obese preeclamptic women
were not found, so comparisons were not possible. Since
the present study is observational, selection bias is pos-
sible. Most obese participants had BMI from 30 to 35
(grade I obesity), so the results could have been different
if there were more women with obesity grades II and III
in the group PE+/OB+. Additionally, the classification
of obesity according to BMI only, without analysis of
body composition, could have resulted in the selection
of pregnant women with a smaller percentage of body
fat, implying in smaller sequestration of circulating
25(OH)D [15].
The newborns vitamin D medians were higher than
those of the mothers in all groups. In a literature review,
Dror & Alen [1] found reports of 25(OH)D levels in
cord blood being as much as 108% higher than those ofthe mothers. The different methods used for measuring
serum vitamin D may partly justify the differences. In line
with other studies [30, 31], the study newborns levels of
vitamin D were positively correlated with those of their
mothers during pregnancy, showing that fetuses are
dependent on maternal serum 25(OH)D levels. However,
according to the coefficients of determination, there was
less maternofetal transfer of 25(OH)D in the groups of
pregnant women with higher BMI. In a recent study,
Josefson et al. [32] also found that obese mothers trans-
ferred less 25(OH)D to their fetuses than nonobese
mothers. Although this fact awaits an explanation, some
hypotheses with a nonlinear explanation have been of-
fered, based on the physiological aspects of placental vita-
min D transportation and the pathophysiology of obesity.
The mechanism by which vitamin D crosses the pla-
centa is not yet clear. Studies from the 1980s [33] and
recent literature reviews [34] report that the main mech-
anism is passive diffusion, as occurs with sex steroid
hormones. The free serum 25(OH)D fraction may reflect
the amount available for cells according to the free
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would cross the cellular lipid bilayer because of its solu-
bility in fat. Karlsson et al. [36] found that obese women
of childbearing age had higher circulating DBP levels
than normal weight women, resulting in a smaller per-
centage of free 25(OH)D. If higher levels of circulating
DBP also occur in obese pregnant women, and placental
transportation of 25(OH)D is passive, smaller maternofetal
transfer of vitamin D is to be expected.
On the other hand, the placenta is a complex organ, and
different clinical contexts may change its structure. The
first months of pregnancy should promote greater placen-
tal expression of the gene CYP27B1, which codifies the en-
zyme 1α-hydroxylase, necessary for the conversion of
calcidiol into calcitriol; and simultaneously silence the gene
CYP24A1, responsible for the catabolism of 25(OH)D and
1,25(OH)2days [29]. In vitro studies have shown that
tumor necrosis factor-alpha (TNF-α) increased CYP24A1
expression in trophoblast cultures [27]. In obese women,
the placenta is inflamed, containing high levels of pro-
inflammatory cytokines [37]. Therefore, the inflamed
placenta of obese women may be an epigenetic factor that
increases placental expression of the gene CYP24A1,
resulting in lower 25(OH)D levels in the maternofetal
interface and consequently, smaller amounts of 25(OH)D
transferred to the fetus.
We believe that future studies, especially in vivo, can elu-
cidate the mechanism by which vitamin D is transported
across the placenta of obese and nonobese women with
and without complications, such as preeclampsia, and
thereby contribute to a better understanding of newborns’
vitamin D status.
The study results must be analyzed in light of its limita-
tions. Measuring 25(OH)D right before delivery reflects its
status only for the past two to three weeks [38]. Moreover,
any biomarker has limitations, either because of physio-
logical factors or the methodological difficulties associated
with its measurement [35]. The main factors capable of af-
fecting 25(OH)D levels are: higher physiological require-
ments, body fat, hemodilution and ageing effects, affinity
of vitamin D for its target tissues, and cellular absorption
efficiency, among others [35]. Although 25(OH)D is the
most widely used marker by clinicians and researchers,
it only indicates vitamin D supply, so it may not be the
best biomarker of biological function [35]. Finally, not
having used the gold standard, high-performance liquid
chromatography (HPLC), to determine the sample’s
vitamin D levels may have returned less accurate
25(OH)D measurements.
It should be emphasized that the present study was con-
ducted close to the equator, at a latitude of 9° south, where
UVB radiation is abundant throughout the four seasons of
the year. This fact alone controlled this geographic con-
founder present in studies conducted at high latitudes.Conclusion
The study found a smaller median and consequently,
worse vitamin D status in mother-newborns dyads with
preeclampsia or gestational obesity. Since obesity be-
came one of the greatest global epidemics at the dawn of
this century, besides the high prevalence of preeclampsia
in pregnancies, we believe that new studies should inves-
tigate whether maternal supplementation with higher
doses of vitamin D can improve the 25(OH)D status of
newborns.
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